
PivotNorth Capital
800 W El Camino Real, Ste 180, Mountain View, California, 94040, United States
Overview
PivotNorth Capital is a venture capital firm in Palo Alto, California. It was founded in 2011 by Tim Connors, formerly of U.S. Venture Partners and Sequoia Capital. PivotNorth raised a 35 million fund when it began in 2011 and sought to raise a second in late 2013.
- Total investments
- 38
- Lead investments
- 12
- Investments · 12mo
- 0
- Active investors
- 1
Sector focus
- Finance
Investment portfolio
- MOGL
Participated · Seed · Mar 2023
Mogl is a New York-based athlete marketplace and NIL operations software provider that connects college athletes with brands and fans for sponsorships, endorsements and video shoutouts. The platform offers compliance and marketplace tools aimed at universities, collectives and brands to facilitate NIL programs and influencer marketing. Mogl plans to expand its compliance and marketplace offerings and broaden its business reach with the new funding. The company is used by over 10,000 student-athletes and more than 1,500 participating businesses and brands, including NBC Sports, Toyota, Under Armour and DoorDash. Co-founded by Brandon Wimbush and CEO Ayden Syal, Mogl positions itself as a comprehensive solution for brands and universities seeking scalable influencer campaigns and insights. The article notes the company closed additional seed financing but does not disclose revenue or valuation.
- Ombre
Led · Seed · Nov 2021
Ombre (formerly Thryve) is a San Francisco-based wellness company that merges science and wellness to deliver individualized self-care. Its offerings include at-home microbiome tests, probiotic subscription services, and tailored lifestyle and diet recommendations. The company recently appointed Elise Contarsy as CEO. Contarsy has prior consumer product branding and merchandising leadership at Bonnier Consumer Products, Meredith Corporation, Bed Bath & Beyond, Martha Stewart Living and Calvin Klein Home. Ombre raised $3M in a Seed round, bringing total funding to $9.5M. The team includes microbiome specialist Kimberly Griffith, Chief Product Officer Piotr Kuczynski, VP B2B Michael Preininger, and merchandise operations manager Liza Wallace. Thryve sells an at-home microbiome testing kit and a monthly subscription that delivers individualized probiotics and a Gut Wellness Score. The company’s core product combines stool-based microbiome analysis with personalized diet and lifestyle recommendations backed by thousands of studies. Samples are processed at a partner laboratory at the University of Chicago Argonne National Laboratory. Subscribers receive monthly boxes (probiotics and reports); subscriptions start at $59.95 per month. Thryve also offers an option for users to contribute anonymized data to support microbiome research and expand scientific knowledge. Company leadership has stated plans to expand Thryve’s products and services and to leverage crowdsourced data for research.
- Viakoo
Participated · Series A · Oct 2021
Viakoo offers an agentless software platform called Viakoo Action that discovers, monitors, and automatically remediates IoT device vulnerabilities across large, multi-vendor deployments. The platform aggregates device data, interoperates with third-party asset discovery tools like Armis and Forescout, and evaluates firmware, password, and 802.1x/TLS certificate status to apply firmware updates, certificate management, and password policy enforcement. Viakoo describes Viakoo Action as a one-click solution that patches different device types almost instantly and at scale, and says it uniquely supports both tightly coupled and loosely coupled devices. The company reports a customer base of over 100, including government agencies, healthcare, education service providers, datacenters, enterprises, and municipal services. Founded in 2013 and based in Mountain View, California, Viakoo plans to use fresh capital to accelerate sales, expand international operations, expand executive leadership, and add development resources for Viakoo Action. The company also claims the solution can pay for itself within months by preventing targeted device attacks; no revenue figures were disclosed in the article.
- Getlabs
Led · Seed · Apr 2021
Getlabs operates an at-home phlebotomy service that sends trained, W-2 phlebotomists to patients’ homes to collect blood samples, which are processed by partners including Labcorp, Quest Diagnostics and Sonora Quest. The company charges an out-of-pocket “convenience fee” starting at $25 for in-home draws. Founded in 2018 by Kyle Michelson, Getlabs aims to be the in-person arm of telehealth, offering an API to integrate lab scheduling directly into virtual visits. Since its seed round the startup has hired over 100 phlebotomists, reports turnover below 0.5%, and expanded coverage to serve roughly 45% of the U.S. population (up from about 6% four months prior), with a target of 60% by year-end. The business is focused on scaling its workforce and forming partnerships with telehealth companies to enable hybrid care models and broader clinical testing access. Getlabs provides at-home blood draws by dispatching phlebotomists to patients and sending samples to partner labs such as Labcorp and Quest Diagnostics. The company charges patients a $29–$49 fee for home draws while insurance covers the lab processing as usual. Getlabs raised a $3 million seed round to fund expansion and has run soft launches in Phoenix, Philadelphia, and Dallas. Founder and CEO Kyle Michelson started the company after experiencing the inconvenience of in-person lab draws during Y Combinator. The fully remote company has 37 employees and plans to expand into other home-health verticals. Getlabs aims to integrate with telemedicine providers so patients can receive more care at home and notes that roughly 70% of medical decisions are based on lab results while about 30% of patients skip lab orders due to inconvenience.
- Ecomedes
Participated · Seed · Mar 2021
Ecomedes is a San Francisco–based developer of a SaaS platform that digitizes building product data management, product research, and the path-to-purchase. Led by CEO Kathleen Egan, the company streamlines collection, maintenance, discovery, research, comparison, documentation, analysis and collaboration for building products. Its platform dynamically links over 750,000 building products to more than 35 ecolabel certifications across 10,000 manufacturing brands. Ecomedes aims to reduce costs, human health risks, carbon, energy, and other environmental impacts of buildings. The company completed a $3.25M seed financing and intends to deploy the funds to build collaboration tools. Ecomedes is a San Francisco-based provider of a SaaS sustainable building product platform for manufacturers, designers, builders and building owners. Led by CEO and co-founder Kathleen Egan, the platform delivers a cross-company system of record for product certifications, requirements, compliance, lifetime energy simulation and price-performance analysis. It streamlines collection, maintenance, discovery, comparison, documentation and performance analysis for more than 700,000 sustainable building products carrying over 35 ecolabel certifications across 10,000 manufacturing brands. Building owners, design teams and general contractors such as the US General Services Administration, KMD Architects and DPR Construction use the system, as do manufacturers including Armstrong, CertainTeed, Humanscale and Tarkett. Ecomedes intends to use the funding to build SaaS collaboration and optimization tools for modern commercial building product selection. Financially, the company raised $1.5M in seed financing from new investor Saint-Gobain NOVA and existing investor PivotNorth.
Team
Tim Connors
Founder
LinkedIn